VEON Deferred Long Term Liab vs Capital Stock Analysis
VEON Stock | USD 25.50 0.08 0.31% |
VEON financial indicator trend analysis is much more than just breaking down VEON prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether VEON is a good investment. Please check the relationship between VEON Deferred Long Term Liab and its Capital Stock accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VEON. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. To learn how to invest in VEON Stock, please use our How to Invest in VEON guide.
Deferred Long Term Liab vs Capital Stock
Deferred Long Term Liab vs Capital Stock Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of VEON Deferred Long Term Liab account and Capital Stock. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between VEON's Deferred Long Term Liab and Capital Stock is -0.59. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Capital Stock in the same time period over historical financial statements of VEON, assuming nothing else is changed. The correlation between historical values of VEON's Deferred Long Term Liab and Capital Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of VEON are associated (or correlated) with its Capital Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Stock has no effect on the direction of Deferred Long Term Liab i.e., VEON's Deferred Long Term Liab and Capital Stock go up and down completely randomly.
Correlation Coefficient | -0.59 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Deferred Long Term Liab
Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.Capital Stock
The total amount of a company’s capital funded by shareholders through the issue and subscription of shares.Most indicators from VEON's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into VEON current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VEON. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. To learn how to invest in VEON Stock, please use our How to Invest in VEON guide.At this time, VEON's Selling General Administrative is very stable compared to the past year. As of the 16th of May 2024, Enterprise Value Over EBITDA is likely to grow to 4.71, though Discontinued Operations is likely to grow to (666 M).
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 5.9B | 3.8B | 3.3B | 3.1B | Total Revenue | 7.8B | 3.8B | 4.3B | 4.1B |
VEON fundamental ratios Correlations
Click cells to compare fundamentals
VEON Account Relationship Matchups
High Positive Relationship
High Negative Relationship
VEON fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 16.1B | 14.6B | 15.9B | 15.1B | 17.4B | 20.8B | |
Other Current Liab | 1.1B | 993M | 1.3B | 6.6B | 2.5B | 2.5B | |
Total Current Liabilities | 5.8B | 4.4B | 4.8B | 6.6B | 7.6B | 5.8B | |
Total Stockholder Equity | 1.2B | 163M | 586M | 776M | 892.4M | 847.8M | |
Retained Earnings | (1.3B) | (1.9B) | (1.2B) | (1.4B) | (1.3B) | (1.2B) | |
Accounts Payable | 1.8B | 2.0B | 2.0B | 1.1B | 1.3B | 1.7B | |
Cash | 1.3B | 1.6B | 2.3B | 3.1B | 3.6B | 2.1B | |
Other Assets | 297M | 365M | 444M | 473M | 544.0M | 603.0M | |
Long Term Debt | 10.0B | 6.6B | 7.8B | 7.6B | 8.7B | 9.2B | |
Short Term Investments | 82M | 165M | 86M | 904M | 1.0B | 1.1B | |
Inventory | 141M | 169M | 111M | 18M | 20.7M | 19.7M | |
Total Liab | 13.8B | 13.5B | 14.4B | 14.3B | 16.5B | 15.8B | |
Intangible Assets | 5.7B | 4.2B | 1.7B | 1.6B | 1.8B | 3.5B | |
Property Plant Equipment | 7.3B | 6.9B | 6.7B | 4.4B | 5.1B | 7.0B | |
Other Liab | 312M | 296M | 238M | 164M | 188.6M | 179.2M | |
Good Will | 4.0B | 2.7B | 1.5B | 394M | 453.1M | 430.4M | |
Short Long Term Debt Total | 10.3B | 10.1B | 10.6B | 7.6B | 6.8B | 10.1B | |
Property Plant And Equipment Net | 7.3B | 6.9B | 6.7B | 4.4B | 4.0B | 6.4B | |
Current Deferred Revenue | 225M | 216M | 212M | 159M | 143.1M | 135.9M | |
Net Debt | 9.1B | 8.5B | 8.4B | 4.5B | 4.0B | 3.8B | |
Non Current Assets Total | 13.6B | 11.7B | 10.5B | 5.3B | 4.8B | 4.5B | |
Non Currrent Assets Other | 163M | 179M | 216M | 473M | 128M | 235.6M | |
Cash And Short Term Investments | 1.3B | 1.8B | 2.3B | 4.0B | 4.6B | 3.1B | |
Net Receivables | 644M | 645M | 920M | 446M | 577M | 924.7M | |
Liabilities And Stockholders Equity | 16.1B | 14.6B | 15.9B | 15.1B | 13.6B | 20.1B | |
Non Current Liabilities Total | 8.1B | 9.1B | 9.6B | 7.7B | 7.0B | 10.0B | |
Other Stockholder Equity | 11.3B | 11.3B | 12.8B | 13.0B | 14.9B | 10.3B | |
Property Plant And Equipment Gross | 7.3B | 6.9B | 16.5B | 6.8B | 7.9B | 9.9B | |
Total Current Assets | 2.5B | 2.9B | 5.4B | 9.8B | 11.3B | 7.0B | |
Accumulated Other Comprehensive Income | (10.2B) | (10.7B) | (10.9B) | (10.8B) | (9.7B) | (9.2B) | |
Short Term Debt | 2.6B | 1.2B | 1.2B | 2.8B | 3.3B | 1.9B | |
Net Tangible Assets | (4.5B) | (4.0B) | (2.7B) | 382M | 439.3M | 461.3M | |
Deferred Long Term Liab | 83M | 101M | 128M | 149M | 171.4M | 179.9M | |
Long Term Investments | 235M | 305M | 99M | 71M | 63.9M | 60.7M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether VEON offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VEON's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Veon Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Veon Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VEON. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. To learn how to invest in VEON Stock, please use our How to Invest in VEON guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for VEON Stock analysis
When running VEON's price analysis, check to measure VEON's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VEON is operating at the current time. Most of VEON's value examination focuses on studying past and present price action to predict the probability of VEON's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VEON's price. Additionally, you may evaluate how the addition of VEON to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is VEON's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VEON. If investors know VEON will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VEON listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.75 | Earnings Share 4.36 | Revenue Per Share 52.656 | Quarterly Revenue Growth 0.061 | Return On Assets 0.0494 |
The market value of VEON is measured differently than its book value, which is the value of VEON that is recorded on the company's balance sheet. Investors also form their own opinion of VEON's value that differs from its market value or its book value, called intrinsic value, which is VEON's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VEON's market value can be influenced by many factors that don't directly affect VEON's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VEON's value and its price as these two are different measures arrived at by different means. Investors typically determine if VEON is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VEON's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.